Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>2000 µM
Hemolytic
Cytotoxic
50% Hemolysis | >2000 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Disruption of drug-resistant biofilms using de novo designed short ?-helical antimicrobial peptides with idealized facial amphiphilicity. | Acta Biomater | 2017